Latest news on Cell and gene therapy CRO market Research Report by 2035 Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.  A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.  Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.  A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.  An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.  A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.  A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Area of Expertise  Cell Therapy  Gene Therapy  Scale of Operation  Preclinical  Clinical  Drug Discovery  Therapeutic Area  Oncological Disorders  Neurological Disorders  Cardiovascular Disorders  Infectious Diseases  Metabolic Disorders  Autoimmune Disorders  Blood Disorders  Rare / Genetic Disorders  Ophthalmic Disorders  Other disorders  Analysis by Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Altasciences  Charles River Laboratories  Creative Biolabs  IQVIA  Medpace  PPD  Precision for Medicine  Accelera  Evotec  ICON  Syneos Health  CMIC Group  Labcorp To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html News article AI-based digital pathology market Learn from experts: do you know about these emerging industry trends? TCR Therapies: An Emerging Therapeutic Modality Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #atmps #genetherapycro #cellandgenetherapycompanies #MarketResearch #MarketInsights

Lab Automation market Share, Growth Analysis by 2035 The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks. As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory. The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:  Stage of Automation  Pre-Analytical  Analytical  Post-Analytical  Total Lab Automation  Type of Instrument  Automated Liquid Handling Systems  Automated Microplate Readers  Automated Sampling Systems  Analyzers  Automated Storage and Retrieval Systems (ASRS)  Other Instruments  End-User  Pharmaceutical and Biotechnology Companies  Research and Diagnostic Laboratories  Other End-Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  Abbott  Anton Paar  BD  Beckman Coulter  ERWEKA  Leuze  Ortho Clinical Diagnostics  Pall Corporation  PerkinElmer  Roche Diagnostics  Siemens Healthineers  SYSTAG Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Competitiveness Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Market Forecast and Opportunity Analysis 10. Case Study: Lab Automation Software 11. Executive Insights 12. Appendix 1: Tabulated Data 13. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications T-cell Immunotherapies: The Future of Modern Cancer Treatments Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #labautomation #laboratoryautomation #laboratoryautomationmarket #MarketResearch #MarketInsights

Cell Free Expression market Analysis and Trends by 2023-2035 The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.” The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:  An executive summary of insights captured during our research.  A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique  A detailed assessment of the current market landscape of cell free expression service providers.  A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.  A comprehensive company competitiveness analysis of cell free expression service providers.  A product competitiveness analysis of cell free expression kits based on various relevant parameters.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.  Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).  A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.  An analysis of the funding and investments made in the cell free expression market, since 2018.  An in-depth analysis of various patents that have been filed / granted related to cell free system since 2015.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Cell Free System • Crude Cell Lysate-based Systems • Reconstituted Systems  Type of Host Organism • Microbial Cell Free Expression Systems • Mammalian Cell Free Expression Systems • Plant-based Cell Free Expression Systems • Other Cell Free Expression Systems  Type of Expression Method • Coupled Transcription and Translation Method • Translation Method  End-User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Other End-Users  Key Geographical Regions • North America • Europe • Asia Pacific • Rest of the World Key companies covered in the report  BioLinker  biotechrabbit  CellFree Sciences  Creative Biolabs  CUSABIO  Daicel Arbor Biosciences  LenioBio  Promega  Thermo Fisher Scientific  Touchlight For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Cellfreeproteinsynthesis #cellfreeproteinsynthesis #cellfreesystem #MarketResearch #MarketInsights

Latest news on mRNA therapeutics and Vaccines market Research Report by 2035 The “mRNA Therapeutics and Vaccines Market: Industry Trends and Global Forecasts, 2022 – 2035” report features an extensive study of the current market landscape and the likely future potential associated with the biopharmaceutical contract manufacturing market, over the next decade. The study also includes an elaborate discussion on the future potential of this evolving market. Amongst other elements, the report features: Key Inclusions  A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters, such as phase of development (marketed, phase III, phase II, phase I / II, phase I, preclinical and discovery), type of drug candidate (mRNA therapeutic and mRNA vaccine), therapeutic area (infectious diseases, oncological disorders, genetic disorders, pulmonary disorders, autoimmune disorders and other disorders), type of delivery system used (lipid nanoparticles, lipopolyplex, liposomes, direct transfer, self-amplifying RNA platform and others), type of molecule encoded (spike protein, glycoprotein, antigen, cytokine, protein coding gene, tumor neoantigen, enzyme, tumor antigen and others) and route of administration (intramuscular, intravenous, intranasal and others).  A detailed overview of the current mRNA therapeutics and mRNA vaccine market of players engaged in the development of mRNA therapeutics and vaccines, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, regional landscape and key players engaged in this domain.  An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.  Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and vaccines, along with information on the development timeline of the therapy, current development status, primary target indication, therapeutic area, type of molecule encoded, type of delivery system used, affiliated technology, recent partnerships associated with the drug, clinical trial results related to the drug and other recent developmental.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021), featuring a [A] heat map representation that highlights mRNA therapeutics and vaccines under development (in partnership with core mRNA-focused entities), along with information on funding amount raised, partnership activity, and diversity of product portfolio (in terms of disease indication(s) being treated and focus therapeutic area(s)), as well as [B] a spider web representation, comparing the initiatives of big pharmaceutical players on the basis of multiple relevant parameters.  An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters, such as number of candidates in discovery, preclinical and clinical phases of development, amount raised, number of investors and number of deals inked.  An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters, such as trial registration year, trial status, trial phase, target therapeutic area, study design, type of sponsor / collaborator, leading industry players (in terms of number of trials conducted), enrolled patient population and key geographical regions.  An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry, based on several relevant parameters, such as year of partnership, type of partnership, targeted therapeutic area, most active players (in terms of number of deals inked) and regional distribution of partnership activity that have been undertaken in this domain, during the period 2013-2022.  A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022, based on several relevant parameters, such as year of funding, type of funding (seed financing, venture capital, IPOs, secondary offerings, debt, grants and other offerings), amount invested, therapeutic area, most active players (in terms of number of funding instances and amount invested) and key investors (in terms of number of funding instances).  An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016, based on several relevant parameters, such as type of patent (granted patents, patent applications and others), publication year, geographical region, CPC symbols, leading industry players (in terms of the number of patents filed / granted) and patent valuation. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Routes of Administration  Intradermal  Intravenous  Intranasal  Others  Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key Questions Answered  Which are the key players engaged in the development of mRNA therapeutics and vaccines?  Which mRNA drug candidates are being evaluated across early and late stages of clinical development?  Which are the key therapeutic areas targeted by mRNA therapeutics and vaccines?  Which type of delivery systems are primarily being used for the delivery of mRNA therapeutics and vaccines?  Which are the most active trial sites (in terms of number of clinical studies being conducted) related to mRNA therapeutics and vaccines?  Which companies are actively filing patents in order to drive innovation in the field of mRNA therapeutics and vaccines?  What type of partnership models are commonly adopted by stakeholders in the mRNA therapeutics and vaccine domain?  Which are the companies that are investing heavily in this domain?  How is the current and future market opportunity likely to be distributed across the various key market segments? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html News article Modular Facility Manufacturers Market Learn from experts: do you know about these emerging industry trends? Novel Cell Cytometers: Need of the Hour Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mrnatherapeuticscompanies #mrnavaccinecompanies #mrnatechnology #MarketResearch #MarketInsights

Digital twin market Share, Growth Analysis by 2035 Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain The USD 29.8 billion (by 2035) financial opportunity within digital twin market has been analyzed across the following segments:  Therapeutic Area  Cardiovascular Disorders  Metabolic Disorders  Orthopedic Disorders  Other Disorders  Type of Digital Twin  Process Twins  System Twins  Whole Body Twins  Body Part Twins  Area of Application  Asset / Process Management  Personalized Treatment  Surgical Planning  Diagnosis  Other Applications  End Users  Pharmaceutical Companies  Medical Device Manufacturers  Healthcare Providers  Patients  Other End Users  Key Geographical Regions  North America  Europe  Asia  Latin America  Middle East and North Africa  Rest of the World The Digital Twins Market, 2022-2035, report features the following companies, which we identified to be key players in this domain:  Babylon  ExactCure  ImmersiveTouch  Navv Systems  ThoughtWire  Unlearn.AI The latest report also provides key insights for Digital Twin Technology and Digital Twins Providers Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Key Insights 6. Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Funding and Investments Analysis 10. Berkus Start-up Valuation Analysis 11. Market Forecast 12. Conclusion 13. Executive insights 14. Appendix I: Tabulated data 15. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/digital-twins-market.html You may also be interested in the following titles: Buffer Preparation Market mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Quantum Computing in Drug Discovery Services Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DigitalTwins #DigitalTwin #DigitalTwinTechnology #MarketResearch #MarketInsights

Bacteriophage therapy market Professional Survey Report by 2035 With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma Table of Content 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. BACTERIO-PHAGE THERAPY: MARKET LANDSCAPE 5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE 6. COMPANY AND DRUG PROFILES 7. CLINICAL TRIAL ANALYSIS 8. PATENT ANALYSIS 9. PUBLICATION BENCHMARKING ANALYSIS 10. ACADEMIC GRANTS ANALYSIS 11. FUNDING AND INVESTMENT ANALYSIS 12. PARTNERSHIPS AND COLLABORATIONS 13. START-UP HEALTH INDEXING 14. MARKET FORECAST AND OPPORTUNITY ANALYSIS 15. CONCLUSION 16. EXECUTIVE INSIGHTS 17. APPENDIX I: TABULATED DATA 18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Cannabis Testing Market Key Trends in Non-Viral Transfection Market CAR-T Cell Therapy Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #bacteriophagetherapy #bacteriophagetherapeutics #phagetherapy #MarketResearch #MarketInsights

Medical Device coating market Growth Analysis by 2035 The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices. Presently, multiple types of medical device coating are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical device coating market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Devices Coated  Class I Medical Devices  Class II Medical Devices  Class III Medical Devices  Type of Coating Material  Polymer Coatings  Metal Coatings  Other Coatings  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Region  North America  Europe  Asia  Rest of the World Key companies covered in the report  Advanced Coating  Biocoat  Evonik  Formacoat  Harland Medical Systems  Para-Coat Technologies  Specialty Coating Systems  SurModics  TUA Systems Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Medical Device Coating Providers: Market Landscape 5. Company Competitiveness Analysis 6. Surface Modification Technologies and Coating Solutions: Market Landscape 7. Product Competitiveness Analysis 8. Medical Device Coating Providers: Company Profiles 9. Partnerships and Collaborations 10. Medical Device Coating Providers: Pestle Analysis 11. Market Forecast 12. Concluding Remarks 13. Executive Insights 14. Appendix 1: Tabulated Data 15. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/medical-device-coatings-market.html You may also be interested in the following titles: Nanoparticle Formulation Market 4D Bioprinting Market: Key Trends Global Digital Therapeutics Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #medicaldevicecoatingindustry #biocompatiblecoating #antimicrobialcoating #MarketResearch #MarketInsights

Medical Device Coatings market 2022 – Industry Growth by 2035 Roots Analysis has done a detailed study on “Medical Device Coatings and Surface Modification Technologies Market, 2023-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities Key Market Insights  Currently, more than 85 companies provide coatings that serve a wide array of functions and are compatible with a diverse array of substrate materials; majority of such players have entered this domain post 2,000  Companies engaged in this industry provide a wide range of coating materials for different types of medical devices; of these, close to 70% of the coatings are being offered for medical implants  In order to gain an edge in this competitive industry, coating providers are continuously undertaking initiatives to upgrade their existing material offerings and coating solutions for medical devices  Presently, more than 115 surface modification technologies and coating solutions are being offered by players to enhance the surface functions and resistance of medical devices  The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions; majority of the players are based in the US  In pursuit of gaining a competitive edge, developers are making an active effort to incorporate advanced technologies into their respective portfolios of coatings / technologies and comply with evolving industry needs  The rising interest of stakeholders in surface modification of medical devices and coating solutions is reflected by the increasing number of partnerships established between various industry and non-industry players  Built on our intellectual capital, we have proposed a proprietary framework that can be applied to strengthen the strategic planning processes and risk management within the industry  With the rising demand for medical device coating solutions and services, the affiliated market for service providers is expected to grow at a steady annualized rate of 7.7% over the coming decade  The opportunity associated with the medical device coatings market is expected to be well distributed among players of different company sizes, with majority of the revenue being coming in from developed regions. Table of Contents 1. PREFACE 1.1. Scope of the Report 1.2. Market Segmentation 1.3. Research Methodology 1.4. Key Questions Answered 1.5. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Chapter Overview 3.2. Medical Device Coatings 3.2.1. Types of Medical Device Coatings 3.2.2. Lubricious Coatings 3.2.3. Antimicrobial Coatings 3.2.4. Hydrophilic Coatings 3.2.5. Advantages and Disadvantages of Medical Device Coatings 3.3. Surface Modification Technologies 3.3.1. Types of Surface Modification Technologies 3.3.2. Advantages and Disadvantages of Surface Modification Technologies 3.4. Future Perspectives 4. MEDICAL DEVICE COATING PROVIDERS: MARKET LANDSCAPE 4.1. Chapter Overview 4.2. Medical Device Coatings Providers: Overall Market Landscape 4.2.1. Analysis by Year of Establishment 4.2.2. Analysis by Company Size 4.2.3. Analysis by Location of Headquarters 4.2.4. Analysis by Type of Company 4.2.5. Analysis by Type of Medical Device(s) Coated 4.2.6. Analysis by Nature of Coating Material(s) 4.2.7. Analysis by Type of Coating Material(s) 4.2.8. Analysis by Type of Coating(s) 4.2.9. Analysis by Type of Coating Function(s) 4.2.10. Analysis by Type of Compatible Substrate(s) 4.2.11. Analysis by Service(s) Offered 4.2.12. Analysis by Additional Feature(s) Offered 5. COMPANY COMPETITIVENESS ANALYSIS 5.1. Chapter Overview 5.2. Assumptions and Key Parameters 5.3. Methodology 5.4. Medical Device Coatings Providers: Company Competitiveness Analysis 5.4.1. Competitiveness Analysis: Very Small Companies 5.4.2. Competitiveness Analysis: Small Companies 5.4.3. Competitiveness Analysis: Mid-sized Companies 5.4.4. Competitiveness Analysis: Large Companies 5.4.5. Competitiveness Analysis: Very Large Companies 6. SURFACE MODIFICATION TECHNOLOGIES AND COATING SOLUTIONS: MARKET LANDSCAPE 6.1. Chapter Overview 6.2. Surface Modification Technologies and Coating Solutions: Overall Market Landscape 6.2.1. Analysis by Type of Medium(s) for Modification 6.2.2. Analysis by Type of Trademark Right 6.2.3. Analysis by Type of Surface Modification Process(s) Employed 6.2.4. Analysis by Type of Device(s) Coated 6.2.5. Analysis by Type of Medical Device(s) Coated 6.2.6. Analysis by Nature of Coating Material(s) 6.2.7. Analysis by Type of Coating(s) Applied 6.2.8. Analysis by Type of Resistance(s) Offered 6.2.9. Analysis by Type of Compatible Substrate(s) 6.2.10. Analysis by Additional Feature(s) Offered 6.3. Medical Device Surface Modification Technologies and Coating Solutions: Developer Landscape 6.3.1. Analysis by Year of Establishment 6.3.2. Analysis by Company Size 6.3.3. Analysis by Location of Headquarters 6.3.4. Most Active Players: Analysis by Number of Products Offered 7. PRODUCT COMPETITIVENESS ANALYSIS 7.1. Chapter Overview 7.2. Assumptions and Key Parameters 7.3. Methodology 7.4. Product Competitiveness Analysis 7.4.1. Product Competitiveness Analysis: Technologies 7.4.1.1. Technologies Developed by Very Small and Small Companies 7.4.1.2. Technologies Developed by Mid-sized Companies 7.4.1.3. Technologies Developed by Large and Very Large Companies 7.4.2. Product Competitiveness Analysis: Coating Solutions 7.4.2.1. Coating Solutions Developed by Very Small and Small Companies 7.4.2.2. Coating Solutions Developed by Mid-sized Companies 7.4.2.3. Coating Solutions Developed by Large and Very Large Companies 8. MEDICAL DEVICE COATING PROVIDERS: COMPANY PROFILES 8.1. Chapter Overview 8.2. Advanced Coating 8.2.1. Company Overview 8.2.2. Recent Developments and Future Outlook 8.3. Biocoat 8.3.1. Company Overview 8.3.2. Recent Developments and Future Outlook 8.4. Evonik Health Care 8.4.1. Company Overview 8.4.2. Recent Developments and Future Outlook 8.5. Formacoat 8.5.1. Company Overview 8.5.2. Recent Developments and Future Outlook 8.6. Harland Medical Systems 8.6.1. Company Overview 8.6.2. Recent Developments and Future Outlook 8.7. Para-Coat Technologies 8.7.1. Company Overview 8.7.2. Recent Developments and Future Outlook 8.8. Specialty Coating Systems 8.8.1. Company Overview 8.8.2. Recent Developments and Future Outlook 8.9. SurModics 8.9.1. Company Overview 8.9.2. Recent Developments and Future Outlook 8.10. TUA Systems 8.10.1. Company Overview 8.10.2. Recent Developments and Future Outlook 9. PARTNERSHIPS AND COLLABORATIONS 9.1. Chapter Overview 9.2. Partnership Models 9.3. List of Partnerships and Collaborations 9.3.1. Analysis by Year of Partnership 9.3.2. Analysis by Type of Partnership 9.3.3. Analysis by Type of Partner 9.3.4. Analysis by Geography 9.3.5. Most Active Players: Analysis by Number of Partnerships 10. MEDICAL DEVICE COATING PROVIDERS: PESTLE ANALYSIS 10.1. Chapter Overview 10.2. Methodology 10.3. Key Factors 10.3.1. Political Factors 10.3.2. Economical Factors 10.3.3. Sociological Factors 10.3.4. Technological Factors 10.3.5. Legal Factors 10.3.6. Environmental Factors 10.4. PESTLE Analysis: Medical Device Coating Providers 10.4.1. Biocoat 10.4.2. Biomerics 10.4.3. Diamond-MT 10.4.4. Evonik Health Care 10.4.5. Fisher Barton 10.4.6. Formacoat 10.4.7. Freudenberg 10.4.8. Harland Medical Systems 10.4.9. Master Bond 10.4.10. Materion 10.4.11. N8 Medical 10.4.12. Para-Coat Technologies 10.4.13. Specialty Coating Systems 10.4.14. SurModics 10.4.15. Tractivus 10.5. Concluding Remarks 11. MARKET FORECAST 11.1. Chapter Overview 11.2. Key Assumptions and Forecast Methodology 11.3. Global Medical Device Coatings Market, 2023-2035 11.3.1. Global Medical Device Coatings Market: Distribution by Type of Medical Devices Coated, 2023 and 2035 11.3.1.1. Medical Device Coatings Market for Class I Devices, 2023-2035 11.3.1.2. Medical Device Coatings Market for Class II Devices, 2023-2035 11.3.1.3. Medical Device Coatings Market for Class III Devices, 2023-2035 11.3.2. Global Medical Device Coatings Market: Distribution by Type of Coating Material, 2023 and 2035 11.3.2.1. Medical Device Coatings Market for Polymer Coatings, 2023-2035 11.3.2.2. Medical Device Coatings Market for Metal Coatings, 2023-2035 11.3.2.3. Medical Device Coatings Market for Other Coatings, 2023-2035 11.3.3. Global Medical Device Coatings Market: Distribution by Company Size, 2023 and 2035 11.3.3.1. Medical Device Coatings Market for Very Small Companies, 2023-2035 11.3.3.2. Medical Device Coatings Market for Small Companies, 2023-2035 11.3.3.3. Medical Device Coatings Market for Mid-sized Companies, 2023-2035 11.3.3.4. Medical Device Coatings Market for Large Companies, 2023-2035 11.3.3.5. Medical Device Coatings Market for Very Large Companies, 2023-2035 11.3.4. Global Medical Device Coatings Market: Distribution by Key Geographical Regions, 2023 and 2035 11.3.4.1. Medical Device Coatings Market in North America, 2023-2035 11.3.4.2. Medical Device Coatings Market in Europe, 2023-2035 11.3.4.3. Medical Device Coatings Market in Asia, 2023-2035 11.3.4.4. Medical Device Coatings Market in the Rest of the World, 2023-2035 12. CONCLUDING REMARKS 13. EXECUTIVE INSIGHTS 13.1. Chapter Overview 13.2. Biocoat 13.2.1. Company Snapshot 13.2.2. Interview Transcript: Mark Eberhardt, Senior Director of Marketing 13.3. N8 Medical 13.3.1. Company Snapshot 13.3.2. Interview Transcript: Carl Genberg, Chief Scientific Officer 13.4. VaporTech 13.4.1. Company Snapshot 13.4.2. Interview Transcript: David Wayne, Director of Sales and Marketing 14. APPENDIX 1: TABULATED DATA 15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/medical-device-coatings-market.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MedicalDeviceCoatingsmarket #MedicalDeviceCoatingsmarketGrowth #MedicalDeviceCoatings #antimicrobialcoatingsformedicaldevices #surfacetreatmenttechnologies

Quantum Computing market 2022 – Industry Growth by 2035 Roots Analysis has announced the addition of “Quantum Computing in Drug Discovery Services Market, 2023-2035” report to its list of offerings. Key Market Insights  Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery  Leveraging their expertise, 86% stakeholders offer such services across target discovery / identification, primarily focusing on oncological disorders  In pursuit of gaining a competitive edge, manufacturers claim to be steadily expanding their existing capabilities in order to enhance their service portfolio related to quantum computing  Grants worth over USD 70 million have been awarded to various organizations that have actively undertaken R&D efforts to evaluate the potential of quantum computing in drug discovery  A considerable increase in the partnership activity has been witnessed in the past few years; close to 50% of the collaborations were inked by firms based in the same region  More than 30 players, worldwide, claim to offer hardware-as-a-service for quantum computing in drug discovery, and have developed the required expertise in different types of computational approaches  Majority of the quantum computing hardware providers, headquartered in North America, were established before the year 2000; in fact, ~50% of the overall market landscape is catered to by large companies.  The rise in the adoption of quantum computing in the biopharmaceutical industry is anticipated to create profitable business opportunities for both software and hardware providers  Based on the pioneer-migrator-settler map, we have classified the software providers into different categories; a selection of pioneers is expected to provide valuable offerings to lead the market in the longer term  We expect the market to grow at an annualized rate of 14% in the coming decade; the opportunity is likely to be well distributed across types of drug discovery services, therapeutic areas and key geographical regions Table of Contents 1. PREFACE 1.1. Introduction 1.2. Key Market Insights 1.3. Scope of the Report 1.4. Research Methodology 1.5. Frequently Asked Questions 1.6. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Overview of Quantum Computing in Drug Discovery 3.2. Drug Discovery and Development Timeline 3.3. Historical Evolution of Computational Drug Discovery Approaches 3.4. Classification of Quantum Computing Approaches 3.5. Applications of Quantum Computing in Drug Discovery Process 3.6. Advantages of Quantum Computing in Drug Discovery 3.7. Challenges Associated with Quantum Computing in Drug Discovery 3.8. Future Perspectives 4. MARKET LANDSCAPE: SOFTWARE PROVIDERS 4.1. Quantum Computing Software Providers: Overall Market Landscape 4.1.1. Analysis by Year of Establishment 4.1.2. Analysis by Company Size 4.1.3. Analysis by Location of Headquarters 4.1.4. Analysis by Business Capabilities 4.1.5. Analysis by Platform Capabilities 4.1.6. Analysis by Type of Drug Discovery Service(s) Offered 4.1.7. Analysis by Type of Molecule(s) Supported 4.1.8. Analysis by Compatible Computational Approaches 4.1.9. Analysis by End User(s) 4.1.10. Analysis by Therapeutic Area(s) 5. COMPANY COMPETITIVENESS ANALYSIS 5.1. Methodology and Key Parameters 5.2 Scoring Criteria 5.3. Company Competitiveness Analysis: Players based in North America (Peer Group I) 5.4. Company Competitiveness Analysis: Players based in Europe (Peer Group II) 5.5. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III) 6. COMPANY PROFILES: SOFTWARE PROVIDERS 6.1. Accenture 6.1.1. Company Overview 6.1.2. Financial Information 6.1.3. Service Portfolio 6.1.4. Recent Developments and Future Outlook 6.2. Atos 6.3. Fujitsu 6.4. Huawei 6.5. Microsoft 6.6. Xanadu 6.7. XtalPi 7. MARKET LANDSCAPE: HARDWARE PROVIDERS 7.1. Quantum Computing Hardware Providers: Overall Market Landscape 7.1.1. Analysis by Year of Establishment 7.1.2. Analysis by Company Size 7.1.3. Analysis by Region of Headquarters 7.1.4. Analysis by Location of Headquarters 7.1.5. Analysis by Type of Offering(s) 7.1.6. Analysis by Data Storage on Cloud 7.1.7. Analysis by Compatible Computational Approaches 7.1.8. Analysis by Type of Offering(s) and Compatible Computational Approaches 8. COMPANY PROFILES: HARDWARE PROVIDERS 8.1. Amazon Web Services 8.1.1. Company Overview 8.1.2. Financial Information 8.1.3. Service Portfolio 8.1.4. Recent Developments and Future Outlook 8.2. IBM 8.3. Microsoft 9. ACADEMIC GRANTS ANALYSIS 9.1. Analysis Methodology 9.2. Key Parameters 9.3. Analysis by Year of Grant 9.4. Analysis by Amount Awarded 9.5. Analysis by Support Period 9.6. Analysis by Study Section 9.7. Word Cloud Analysis: Emerging Focus Areas 9.8. Analysis by Administering Institute Center 9.9. Analysis by Type of Grant 9.10. Analysis by Activity Code 9.11. Analysis by Purpose of Grant 9.12. Analysis by Administering Institute Center and Support Period 9.13. Prominent Program Officers: Analysis by Number of Grants 9.14. Analysis by Location of Recipient Organizations 9.15. Analysis by Type of Organization 9.16. Popular Recipient Organizations: Analysis by Number of Grants 9.17. Popular Recipient Organizations: Analysis by Amount Awarded 10. PARTNERSHIPS AND COLLABORATIONS 10.1. Partnership Models 10.2. Quantum Computing in Drug Discovery, Drug Manufacturing and Other Services: Partnerships and Collaborations 10.3. Analysis by Year of Partnership 10.4. Analysis by Type of Partnership 10.5. Analysis by Year and Type of Partnership 10.6. Most Active Players: Analysis by Number of Partnerships 10.7. Word Cloud Analysis: Key Focus Areas 10.8. Analysis by Type of Continent 10.9. Analysis by Company Size and Type of Partnership 10.10. Local and Intercontinental Agreements 10.11. Intercontinental and Intracontinental Agreements 11. USE CASE STUDY 11.1. Overview of Quantum Computing 11.2. Applications of Quantum Computing Across Various Industries 11.3. Upcoming Trends in Quantum Computing 11.4. Future Perspectives 12. PORTER’S FIVE FORCES ANALYSIS 12.1. Methodology and Assumptions 12.2. Key Parameters 12.2.1. Threats of New Entrants 12.2.2. Bargaining Power of Buyers 12.2.3. Bargaining Power of Suppliers 12.2.4. Threats of Substitute Products 12.2.5. Rivalry among Existing Competitors 13. BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET 13.1. Overview of Blue Ocean Strategy 13.1.1 Red Oceans 13.1.2 Blue Oceans 13.1.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy 13.1.4. Quantum Computing in Drug Discovery Services Market: Blue Ocean Strategy and Shift Tools 13.1.4.1. Value Innovation 13.1.4.2. Strategy Canvas 13.1.4.3. Four Action Framework 13.1.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid 13.1.4.5. Six Path Framework 13.1.4.6. Pioneer-Migrator-Settler (PMS) Map 13.1.4.7. Three Tiers of Non-customers 13.1.4.8. Sequence of Blue Ocean Strategy 13.1.4.9. Buyer Utility Map 13.1.4.10. The Price Corridor of the Mass 13.1.4.11. Four Hurdles to Strategy Execution 13.1.4.12. Tipping Point Leadership 13.1.4.13. Fair Process 14. MARKET SIZING AND OPPORTUNITY ANALYSIS 14.1. Forecast Methodology and Key Assumptions 14.2. Quantum Computing in Drug Discovery Services Market, 2023-2035 14.2.1. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Type of Drug Discovery Service Offered 14.2.1.1. Quantum Computing in Drug Discovery Services Market for Target Identification / Validation, 2023-2035 14.2.1.2. Quantum Computing in Drug Discovery Services Market for Hit Generation / Lead Identification, 2023-2035 14.2.1.3. Quantum Computing in Drug Discovery Services Market for Target Lead Optimization, 2023-2035 14.2.2. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Therapeutic Area 14.2.2.1. Quantum Computing in Drug Discovery Services Market for Cardiovascular Disorders, 2023-2035 14.2.2.2. Quantum Computing in Drug Discovery Services Market for CNS Disorders, 2023-2035 14.2.2.3. Quantum Computing in Drug Discovery Services Market for Dermatological Disorders, 2023-2035 14.2.2.4. Quantum Computing in Drug Discovery Services Market for Endocrine Disorders, 2023-2035 14.2.2.5. Quantum Computing in Drug Discovery Services Market for Gastrointestinal Disorders, 2023-2035 14.2.2.6. Quantum Computing in Drug Discovery Services Market for Immunological Disorders, 2023-2035 14.2.2.7. Quantum Computing in Drug Discovery Services Market for Infectious Diseases, 2023-2035 14.2.2.8. Quantum Computing in Drug Discovery Services Market for Musculoskeletal Disorders, 2023-2035 14.2.2.9. Quantum Computing in Drug Discovery Services Market for Oncological Disorders, 2023-2035 14.2.2.10. Quantum Computing in Drug Discovery Services Market for Respiratory Disorders, 2023-2035 14.2.2.11. Quantum Computing in Drug Discovery Services Market for Others, 2023-2035 14.2.3. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Key Geographical Regions 14.2.3.1. Quantum Computing in Drug Discovery Services Market in North America, 2023-2035 14.2.3.1.1. Quantum Computing in Drug Discovery Services Market in the US, 2023-2035 14.2.3.1.2. Quantum Computing in Drug Discovery Services Market in Canada, 2023-2035 14.2.3.2. Quantum Computing in Drug Discovery Services Market for Europe, 2023-2035 14.2.3.2.1. Quantum Computing in Drug Discovery Services Market in the UK, 2023-2035 14.2.3.2.2. Quantum Computing in Drug Discovery Services Market in France, 2023-2035 14.2.3.1.3. Quantum Computing in Drug Discovery Services Market in Germany, 2023-2035 14.2.3.1.4. Quantum Computing in Drug Discovery Services Market in Rest of the Europe, 2023-2035 14.2.3.3. Quantum Computing in Drug Discovery Services Market in Asia-Pacific, 2023-2035 14.2.3.3.1. Quantum Computing in Drug Discovery Services Market in China, 2023-2035 14.2.3.3.2. Quantum Computing in Drug Discovery Services Market in Japan, 2023-2035 14.2.3.3.3. Quantum Computing in Drug Discovery Services Market in Rest of Asia-Pacific, 2023-2035 14.2.3.4. Quantum Computing in Drug Discovery Services Market in Latin America, 2023-2035 14.2.3.5. Quantum Computing in Drug Discovery Services Market in Middle East and North Africa, 2023-2035 15. EXECUTIVE INSIGHTS 16. APPENDIX 1: TABULATED DATA 17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html You may also be interested in the following titles: Lab Automation Market Cannabis Testing Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #QuantumComputingMarket #QuantumComputingMarketSize #quantumcomputinginhealthcare #quantumcomputingindrugdiscovery #quantumcomputing

3D Bioprinting: Intellectual Property Landscape market 2022 – Industry Growth by 2035 The new market report titled ‘3D Bioprinting: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of 3D bioprinting. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain. To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/3d-bioprinting-intellectual-property-landscape.html Main Chapters in the 3D Bioprinting Intellectual Property Landscape Report  Overall Intellectual Property Landscape An analytical perspective of the various patents and affiliated IP documents that have been published related to 3D bioprinting, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this domain.  Popular / Relevant Prior Art Search Expressions An examination of IP literature, shortlisting key words and phrases used to describe 3D bioprinting. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.  Patent Valuation Analysis A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.  Patentability and Freedom to Operate A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.  Analysis of Patent Applications and Granted 3D Bioprinting Patents A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to 3D bioprinting, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.  Pockets of Innovation and White Spaces An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.  Claim Analysis One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim. Key Companies Profiled  Hewlett-Packard (HP)  CELLINK  Organovo  Revotek  ROKIT Healthcare  T&R Biofab  Aspect Biosystems  Prellis Biologics  Advanced Solutions Life Sciences  Cyfuse To understand the complete structure of the report, get its PDF sample copy https://www.rootsanalysis.com/reports/3d-bioprinting-intellectual-property-landscape/request-sample.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Threedimensionalbioprinting #3dbioprintingpatents #3Dbioprinting #3Dbioprintinginvestments #3DbioprintingIPlandscape